Isolation and characterization of thrombin-activated human factor VIII
- PMID: 8119969
Isolation and characterization of thrombin-activated human factor VIII
Abstract
Recombinant human factor VIII (fVIII) was activated by thrombin at pH 7.4, followed by CM-Sepharose chromatography at pH values ranging from 3.5 to 7.4. Optimal coagulant activity was recovered at pH 5.5 and was associated with the isolation of an A1/A2/A3-C1-C2 heterotrimer. The activity was stable at -80 degrees C, but decayed slowly (t1/2 approximately 1 week) and nonproteolytically at room temperature or 4 degrees C. The coagulant activity of the pH 5.5 fVIIIa preparation assayed in human hemophilia A plasma was only 20% that of porcine factor VIIIa. However, its activity was approximately 75% that of porcine fVIIIa in a plasma-free assay, indicating that human fVIIIa is unstable relative to porcine fVIIIa during the coagulation assay. The first-order rate constant for spontaneous, nonproteolytic loss of activity of human fVIIIa at pH 7.4 was decreased 8-fold by fIXa and phospholipid, indicating that human fVIIIa is stabilized when incorporated into the intrinsic pathway factor X activation complex.
Similar articles
-
Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.J Biol Chem. 1998 Oct 23;273(43):27918-26. doi: 10.1074/jbc.273.43.27918. J Biol Chem. 1998. PMID: 9774404
-
Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.J Thromb Haemost. 2006 Jun;4(6):1315-22. doi: 10.1111/j.1538-7836.2006.01951.x. J Thromb Haemost. 2006. PMID: 16706977
-
Coagulant properties of hybrid human/porcine factor VIII molecules.J Biol Chem. 1992 Nov 25;267(33):23652-7. J Biol Chem. 1992. PMID: 1429706
-
Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex.Trends Cardiovasc Med. 1999 Oct;9(7):185-92. doi: 10.1016/s1050-1738(00)00019-0. Trends Cardiovasc Med. 1999. PMID: 10881749 Review.
-
Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity.Int J Hematol. 2020 Jan;111(1):20-30. doi: 10.1007/s12185-018-2545-9. Epub 2018 Oct 22. Int J Hematol. 2020. PMID: 30350119 Review.
Cited by
-
Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.Proc Natl Acad Sci U S A. 2008 May 27;105(21):7416-21. doi: 10.1073/pnas.0801735105. Epub 2008 May 20. Proc Natl Acad Sci U S A. 2008. PMID: 18492805 Free PMC article.
-
The molecular basis of factor V and VIII procofactor activation.J Thromb Haemost. 2009 Dec;7(12):1951-61. doi: 10.1111/j.1538-7836.2009.03622.x. Epub 2009 Sep 18. J Thromb Haemost. 2009. PMID: 19765210 Free PMC article. Review.
-
Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.J Thromb Haemost. 2016 May;14(5):1021-30. doi: 10.1111/jth.13292. Epub 2016 Mar 21. J Thromb Haemost. 2016. PMID: 26878264 Free PMC article.
-
Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.Haematologica. 2015 Jun;100(6):748-56. doi: 10.3324/haematol.2014.116863. Epub 2015 Mar 13. Haematologica. 2015. PMID: 25769543 Free PMC article.
-
Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus.Biophys J. 2007 Dec 1;93(11):3963-76. doi: 10.1529/biophysj.106.100164. Epub 2007 Aug 17. Biophys J. 2007. PMID: 17704148 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous